At the Scarlet Notified Body Summit 2026, one message came through clearly: healthcare regulation is shifting focus. The conversations taking place between regulators, innovators and healthcare organisations are no longer centred solely on whether technology introduces risk, but increasingly on what happens when systems fail to evolve quickly enough to meet growing clinical and operational pressures.
For NHS organisations navigating rising demand, workforce constraints and increasingly complex care pathways, that shift matters.
Among the most significant themes discussed at the Summit were three emerging directions from the MHRA: a broader view of risk that includes the cost of inaction alongside the cost of action, a stronger focus on real-world post-market surveillance, and a move towards more context-specific regulation.
Together, these changes signal a regulatory environment that is becoming more dynamic, more operationally focused, and more closely aligned to how technology performs in everyday clinical settings. For referral management, the implications are substantial.
Referral pathways sit at one of the most critical points in the patient journey. A delayed, incomplete or rejected referral is not simply an administrative issue – it represents lost clinical time, delays to patient care, additional workload across the system, and in some cases, avoidable patient safety risk.
As healthcare systems place greater emphasis on measurable outcomes, interoperability and pathway efficiency, referral quality becomes increasingly important not just operationally, but strategically.
The discussion at the Summit reinforced something already being experienced across the NHS: poorly structured referral processes create downstream inefficiencies that multiply across the patient pathway. Missing information, inconsistent pathway adherence, duplicate data entry and inappropriate referrals all contribute to unnecessary delays and additional pressure on already stretched services.
In a regulatory landscape increasingly focused on real-world effectiveness, tools that actively reduce these risks and support safer, faster decision-making become part of the safety solution itself.
One of the clearest shifts discussed at the Summit was the move away from viewing compliance as a fixed, point-in-time exercise. Instead, regulators are increasingly looking at how products behave in live operational environments over time.
For NHS organisations, this places greater importance on systems that can support consistency, auditability and ongoing quality assurance within routine clinical workflows.
This is particularly relevant as AI and automation become more embedded within healthcare environments. While innovation continues to accelerate, healthcare organisations still need clinically validated structures that ensure referrals remain safe, complete and aligned to local commissioning requirements.
The conversation is no longer simply about introducing new technologies. It is about ensuring those technologies operate within clinically governed, measurable and interoperable processes.
At DXS, these principles are already embedded within how SMART Referrals operates across primary care.
DXS processes well over a million NHS referrals annually across England, supporting clinicians with structured workflows designed to improve referral quality and reduce avoidable variation.
Key features already aligned to the evolving regulatory direction include:
These capabilities help clinicians complete referrals more efficiently while improving the quality and usability of information received downstream by secondary and community care services.
Importantly, they also create stronger operational foundations for future innovation, including the safe adoption of AI-supported workflows and decision-support tools.
Another important theme from the Summit was the need to design for continual change rather than fixed end states. NHS organisations are already operating within a landscape of ongoing transformation – from neighbourhood health models and integrated care delivery to evolving commissioning structures and increasing digital expectations.
In that environment, referral systems need to be adaptable, clinically governed and operationally resilient.
The direction of travel is becoming clearer: healthcare technology will increasingly be evaluated not only on innovation, but on demonstrable real-world impact, pathway safety and measurable operational value.
For referral management, getting the basics right is no longer just good operational practice. It is becoming a core part of delivering safer, more efficient and more sustainable healthcare systems.
Interested in how SMART Referrals can support safer, more efficient referral pathways in your organisation? Get in touch – hello@dxs-systems.co.uk
